ArticleGene therapy2003

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.

N Eliopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.